<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33287823</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1742-2094</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of neuroinflammation</Title><ISOAbbreviation>J Neuroinflammation</ISOAbbreviation></Journal><ArticleTitle>Analysis of ALS-related proteins during herpes simplex virus-2 latent infection.</ArticleTitle><Pagination><StartPage>371</StartPage><MedlinePgn>371</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">371</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12974-020-02044-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Genetics have provided hints on potential molecular pathways involved in neurodegenerative diseases (NDD). However, the number of cases caused exclusively by genetic alterations is low, suggesting an important contribution of environmental factors to NDDs. Among these factors, viruses like herpes simplex viruses (HSV-2), capable of establishing lifelong infections within the nervous system (NS), are being proposed to have a role in NDDs. Despite promising data, there is a significant lack of knowledge on this and an urgent need for more research.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We have set up a mouse model to study HSV latency and its associated neuroinflammation in the spinal cord. The goal of this model was to observe neuroinflammatory changes caused by HSV latent infections, and if those changes were similar to alterations observed in the spinal cord of amyotrophic lateral sclerosis (ALS) patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In infected spinal cords, we have observed a strong leukocyte infiltration and a severe alteration of microglia close to motor neurons. We have also analyzed ALS-related proteins: we have not found changes in TDP-43 and Fus in neurons, but interestingly, we have found decreased protein levels of C9orf72, of which coding gene is severely altered in some familial forms of ALS and is critical for microglia homeostasis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Latent infection of HSV in the spinal cord showed altered microglia and leukocyte infiltration. These inflammatory features resembled to those observed in the spinal cord of ALS patients. No changes mimicking ALS neuropathology, such as TDP-43 cytoplasmic inclusions, were found in infected spinal cords, but a decrease in protein levels of C9orf72 was observed. Then, further studies should be required to determine whether HSV-2 has a role in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cabrera</LastName><ForeName>Jorge Rub&#xe9;n</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Secci&#xf3;n Inmunolog&#xed;a, Laboratorio InmunoBiolog&#xed;a Molecular, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria Gregorio Mara&#xf1;&#xf3;n (IiSGM), Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Plataforma de Laboratorio, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Izquierdo</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Secci&#xf3;n Inmunolog&#xed;a, Laboratorio InmunoBiolog&#xed;a Molecular, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria Gregorio Mara&#xf1;&#xf3;n (IiSGM), Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Plataforma de Laboratorio, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez</LastName><ForeName>Jos&#xe9; Luis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria Gregorio Mara&#xf1;&#xf3;n (IiSGM), Madrid, Espa&#xf1;a. joseluis.jimenez@salud.madrid.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Plataforma de Laboratorio, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain. joseluis.jimenez@salud.madrid.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Spain HIV HGM BioBanco, Madrid, Spain. joseluis.jimenez@salud.madrid.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), C/Dr. Esquerdo 46, 28007, Madrid, Spain. joseluis.jimenez@salud.madrid.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz-Fern&#xe1;ndez</LastName><ForeName>Mar&#xed;a &#xc1;ngeles</ForeName><Initials>M&#xc1;</Initials><Identifier Source="ORCID">0000-0002-0813-4500</Identifier><AffiliationInfo><Affiliation>Secci&#xf3;n Inmunolog&#xed;a, Laboratorio InmunoBiolog&#xed;a Molecular, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain. mmunoz.hgugm@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria Gregorio Mara&#xf1;&#xf3;n (IiSGM), Madrid, Espa&#xf1;a. mmunoz.hgugm@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Spain HIV HGM BioBanco, Madrid, Spain. mmunoz.hgugm@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), C/Dr. Esquerdo 46, 28007, Madrid, Spain. mmunoz.hgugm@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RD16/0025/0019; RETIC PT17/0015/0042; PI16/01863; PI19/01638; CIBER-BBN</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>PI17/01115</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>B2017/BMD-3703</GrantID><Agency>Comunidad de Madrid</Agency><Country/></Grant><Grant><GrantID>NAWA International Academic Partnership Programme</GrantID><Agency>Uniwersytet &#x141;&#xf3;dzki</Agency><Country/></Grant><Grant><GrantID>COST Action CA 17140 "Cancer Nanomedicine from the Bench to the Bedside"</GrantID><Agency>European Cooperation in Science and Technology</Agency><Country/></Grant><Grant><GrantID>EPIICAL Project</GrantID><Agency>PENTA FOUNDATION</Agency><Country/></Grant><Grant><GrantID>Intramural COV20/MAM-BIS</GrantID><Agency>IiSGM</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neuroinflammation</MedlineTA><NlmUniqueID>101222974</NlmUniqueID><ISSNLinking>1742-2094</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606498">C9orf72 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006558" MajorTopicYN="N">Herpes Genitalis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018258" MajorTopicYN="N">Herpesvirus 2, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085343" MajorTopicYN="N">Latent Infection</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014621" MajorTopicYN="N">Vagina</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">C9ORF72</Keyword><Keyword MajorTopicYN="N">Herpes simplex virus</Keyword><Keyword MajorTopicYN="N">Latency</Keyword><Keyword MajorTopicYN="N">Microglia</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Spinal cord</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>8</Day><Hour>5</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33287823</ArticleId><ArticleId IdType="pmc">PMC7722435</ArticleId><ArticleId IdType="doi">10.1186/s12974-020-02044-4</ArticleId><ArticleId IdType="pii">10.1186/s12974-020-02044-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bertram L, Tanzi RE, Bertram L, Tanzi RE. The genetic epidemiology of neurodegenerative disease Find the latest version: review series The genetic epidemiology of neurodegenerative disease. J Clin Invest. 2005;115(6):1449&#x2013;1457. doi: 10.1172/JCI24761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI24761</ArticleId><ArticleId IdType="pmc">PMC1137006</ArticleId><ArticleId IdType="pubmed">15931380</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan L, Cookson MR, Petrucelli L, La Spada AR. Converging pathways in neurodegeneration, from genetics to mechanisms. Nat Neurosci. 2018;21(10):1300&#x2013;1309. doi: 10.1038/s41593-018-0237-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0237-7</ArticleId><ArticleId IdType="pmc">PMC6278826</ArticleId><ArticleId IdType="pubmed">30258237</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson CB, Wozniak MA, Itzhaki RF. Do infectious agents play a role in dementia? Trends Microbiol. 2003;11(7):312&#x2013;317. doi: 10.1016/S0966-842X(03)00146-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0966-842X(03)00146-X</ArticleId><ArticleId IdType="pubmed">12875814</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Miranda-Saksena M, Saksena NK. Viruses and neurodegeneration. Virol J. 2013;10:1&#x2013;17. doi: 10.1186/1743-422X-10-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-1</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields BN, Knipe DM, Howley PM. Fields Virology. 6. 2013. p. 3177.</Citation></Reference><Reference><Citation>Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host Microbe. 2013;13(4):379&#x2013;393. doi: 10.1016/j.chom.2013.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2013.03.010</ArticleId><ArticleId IdType="pmc">PMC3647473</ArticleId><ArticleId IdType="pubmed">23601101</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296(8):964&#x2013;973. doi: 10.1001/jama.296.8.964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.296.8.964</ArticleId><ArticleId IdType="pubmed">16926356</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Tang Q, Hendricks RL. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J Virol. 1996;70(1):264&#x2013;271. doi: 10.1128/JVI.70.1.264-271.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.70.1.264-271.1996</ArticleId><ArticleId IdType="pmc">PMC189813</ArticleId><ArticleId IdType="pubmed">8523535</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques CP, Cheeran MC-J, Palmquist JM, Hu S, Urban SL, Lokensgard JR. Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis. J Immunol. 2008;181(9):6417&#x2013;6426. doi: 10.4049/jimmunol.181.9.6417.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.9.6417</ArticleId><ArticleId IdType="pmc">PMC2614272</ArticleId><ArticleId IdType="pubmed">18941232</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoll MP, Proen&#xe7;a JT, Efstathiou S. The molecular basis of herpes simplex virus latency. FEMS Microbiol Rev. 2012;36(3):684&#x2013;705. doi: 10.1111/j.1574-6976.2011.00320.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2011.00320.x</ArticleId><ArticleId IdType="pmc">PMC3492847</ArticleId><ArticleId IdType="pubmed">22150699</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman LT, Ellison AR, Voytek CC, Yang L, Krause P, Margolis TP. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci U S A. 2002;99(2):978&#x2013;983. doi: 10.1073/pnas.022301899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.022301899</ArticleId><ArticleId IdType="pmc">PMC117416</ArticleId><ArticleId IdType="pubmed">11773630</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell TA, Tscharke DC. Lytic promoters express protein during herpes simplex virus latency. PLoS Pathog. 2016;12(6):1&#x2013;20. doi: 10.1371/journal.ppat.1005729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005729</ArticleId><ArticleId IdType="pmc">PMC4922595</ArticleId><ArticleId IdType="pubmed">27348812</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins-McMillen D, Goodrum FD. The loss of binary: pushing the herpesvirus latency paradigm. Curr Clin Microbiol Rep. 2017;4(3):124&#x2013;131. doi: 10.1007/s40588-017-0072-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40588-017-0072-8</ArticleId><ArticleId IdType="pmc">PMC5726573</ArticleId><ArticleId IdType="pubmed">29250481</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki RF. Corroboration of a major role for herpes simplex virus type 1 in Alzheimer&#x2019;s disease. Front Aging Neurosci. 2018;10(OCT):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6202583</ArticleId><ArticleId IdType="pubmed">30405395</ArticleId></ArticleIdList></Reference><Reference><Citation>Readhead B, Haure-Mirande JV, Funk CC, Richards MA, Shannon P, Haroutunian V, et al. Multiscale analysis of independent Alzheimer&#x2019;s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus. Neuron. 2018;99(1):64&#x2013;82.e7. doi: 10.1016/j.neuron.2018.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.05.023</ArticleId><ArticleId IdType="pmc">PMC6551233</ArticleId><ArticleId IdType="pubmed">29937276</ArticleId></ArticleIdList></Reference><Reference><Citation>Eimer WA, Vijaya Kumar DK, Navalpur Shanmugam NK, Rodriguez AS, Mitchell T, Washicosky KJ, et al. Alzheimer's Disease-Associated beta-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection. Neuron. 2018;99:56&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6075814</ArticleId><ArticleId IdType="pubmed">30001512</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzeng NS, Chung CH, Lin FH, Chiang CP, Yeh CB, Huang SY, et al. Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections&#x2014;a nationwide, population-based cohort study in Taiwan. Neurotherapeutics. 2018;15:417&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935641</ArticleId><ArticleId IdType="pubmed">29488144</ArticleId></ArticleIdList></Reference><Reference><Citation>De Chiara G, Piacentini R, Fabiani M, Mastrodonato A, Marcocci ME, Limongi D, et al. Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice. PLoS Pathog. 2019;15(3):1&#x2013;30. doi: 10.1371/journal.ppat.1007617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007617</ArticleId><ArticleId IdType="pmc">PMC6417650</ArticleId><ArticleId IdType="pubmed">30870531</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston C, Corey L. Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract shedding. Clin Microbiol Rev. 2016;29:149&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4771215</ArticleId><ArticleId IdType="pubmed">26561565</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger JR, Houff S. Neurological complications of herpes simplex virus type 2 infection. Arch Neurol. 2008;65(5):596&#x2013;600. doi: 10.1001/archneur.65.5.596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.5.596</ArticleId><ArticleId IdType="pubmed">18474734</ArticleId></ArticleIdList></Reference><Reference><Citation>Plummer G, Waner JL, Bowling CP. Comparative studies of type 1 and type 2 &amp; &#x201c;herpes simplex&#x201d; viruses. Br J Exp Pathol. 1968;49(2):202&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2093874</ArticleId><ArticleId IdType="pubmed">4296465</ArticleId></ArticleIdList></Reference><Reference><Citation>Provinciali L, Laurenzi MA, Vesprini L, Giovagnoli AR, Bartocci C, Montroni M, et al. Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets. Acta Neurol Scand. 1988;78(6):449&#x2013;454. doi: 10.1111/j.1600-0404.1988.tb03686.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1988.tb03686.x</ArticleId><ArticleId IdType="pubmed">3265563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri-de-Barros JE, Moreira M. Amyotrophic lateral sclerosis and herpes virus: a casual or causal association? Twelve years after. Arq Neuropsiquiatr. 2010;68(6):978. doi: 10.1590/S0004-282X2010000600033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0004-282X2010000600033</ArticleId><ArticleId IdType="pubmed">21243269</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):351&#x2013;360. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, Stauffer JE, Schulte DJ, Ravits J. Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol Clin. 2015;33(4):855&#x2013;876. doi: 10.1016/j.ncl.2015.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.012</ArticleId><ArticleId IdType="pmc">PMC4628785</ArticleId><ArticleId IdType="pubmed">26515626</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol. 1992;140(3):691&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886170</ArticleId><ArticleId IdType="pubmed">1347673</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, Engelhardt JI, Sikl&#xf3;s L, Simpson EP, Kim SH, Pan T, et al. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol. 2004;55:221&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">14755726</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, Siddiqui S, Gabriely G, Lanser A, Dake B, Gopal M, et al. Modulation of inflammatory monocytes with a unique microRNA-gene signature ameliorates ALS mice. J Neuroimmunol. 2012;253(1&#x2013;2):63.</Citation></Reference><Reference><Citation>Zondler L, M&#xfc;ller K, Khalaji S, Bliederh&#xe4;user C, Ruf WP, Grozdanov V, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132(3):391&#x2013;411. doi: 10.1007/s00401-016-1548-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1548-y</ArticleId><ArticleId IdType="pubmed">26910103</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME, Baloh RH. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2019;137(5):715&#x2013;730. doi: 10.1007/s00401-018-1933-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1933-9</ArticleId><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanedo-Vazquez D, Bosque-Varela P, Sainz-Pelayo A, Riancho J. Infectious agents and amyotrophic lateral sclerosis: another piece of the puzzle of motor neuron degeneration. J Neurol. 2019;266(1):27&#x2013;36. doi: 10.1007/s00415-018-8919-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8919-3</ArticleId><ArticleId IdType="pubmed">29845377</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chi&#xf2; A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabakaran T, Bodda C, Krapp C, Zhang BC, Christensen MH, Sun C, et al. Attenuation of cGAS-STING signaling is mediated by a p62/SQSTM1-dependent autophagy pathway activated by TBK1. EMBO J. 2018;37:e97858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5897779</ArticleId><ArticleId IdType="pubmed">29496741</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinert LS, Lopu&#x161;n&#xe1; K, Winther H, Sun C, Thomsen MK, Nandakumar R, et al. Sensing of HSV-1 by the cGAS-STING pathway in microglia orchestrates antiviral defence in the CNS. Nat Commun. 2016;7:13348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5109551</ArticleId><ArticleId IdType="pubmed">27830700</ArticleId></ArticleIdList></Reference><Reference><Citation>Yordy B, Iijima N, Huttner A, Leib D, Iwasaki A. A neuron-specific role for autophagy in antiviral defense against herpes simplex virus. Cell Host Microbe. 2012;12(3):334&#x2013;345. doi: 10.1016/j.chom.2012.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2012.07.013</ArticleId><ArticleId IdType="pmc">PMC3454454</ArticleId><ArticleId IdType="pubmed">22980330</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Sim&#xf3;n-S&#xe1;nchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Rothstein JD. The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease. Nat Rev Neurosci. 2016;17(6):383&#x2013;395. doi: 10.1038/nrn.2016.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2016.38</ArticleId><ArticleId IdType="pmc">PMC7376590</ArticleId><ArticleId IdType="pubmed">27150398</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14(9):544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick P, Sellier C, Mackenzie IRA, Cheng CY, Tahraoui-Bories J, Martinat C, et al. Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers. Acta Neuropathol Commun. 2018;6(1):72. doi: 10.1186/s40478-018-0579-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0579-0</ArticleId><ArticleId IdType="pmc">PMC6091050</ArticleId><ArticleId IdType="pubmed">30075745</ArticleId></ArticleIdList></Reference><Reference><Citation>Amick J, Ferguson SM. C9orf72: at the intersection of lysosome cell biology and neurodegenerative disease. Traffic. 2017;18(5):267&#x2013;276. doi: 10.1111/tra.12477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12477</ArticleId><ArticleId IdType="pmc">PMC5389918</ArticleId><ArticleId IdType="pubmed">28266105</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke JG, Bogdanik L, Y&#xe1;&#xf1;ez A, Lall D, Wolf AJ, Muhammad AKMG, et al. C9orf72 is required for proper macrophage and microglial function in mice. Science (80- ) 2016;351(6279):1324&#x2013;1329. doi: 10.1126/science.aaf1064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, Suzuki N, Wang JY, Moccia R, Mordes DA, Stewart MH, et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci Transl Med. 2016;8:347ra393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasio A, Decman V, White D, Ramos M, Ikiz B, Lee HC, et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci Rep. 2016;6(March):1&#x2013;14. doi: 10.1038/srep23204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23204</ArticleId><ArticleId IdType="pmc">PMC4793236</ArticleId><ArticleId IdType="pubmed">26979938</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME, O&#x2019;Rourke JG, Y&#xe1;&#xf1;ez A, Markman JL, Ho R, Wang X, et al. C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature. 2020;585(7823):96&#x2013;101. doi: 10.1038/s41586-020-2625-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2625-x</ArticleId><ArticleId IdType="pmc">PMC7484469</ArticleId><ArticleId IdType="pubmed">32814898</ArticleId></ArticleIdList></Reference><Reference><Citation>Conrady CD, Zheng M, van Rooijen N, Drevets DA, Royer D, Alleman A, et al. Microglia and a functional type I IFN pathway are required to counter HSV-1&#x2013;driven brain lateral ventricle enlargement and encephalitis. J Immunol. 2013;190(6):2807&#x2013;2817. doi: 10.4049/jimmunol.1203265.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1203265</ArticleId><ArticleId IdType="pmc">PMC3594081</ArticleId><ArticleId IdType="pubmed">23382563</ArticleId></ArticleIdList></Reference><Reference><Citation>Menendez CM, Carr DJJ. Herpes simplex virus-1 infects the olfactory bulb shortly following ocular infection and exhibits a long-term inflammatory profile in the form of effector and HSV-1-specific T cells. J Neuroinflammation. 2017;14(1):1&#x2013;11. doi: 10.1186/s12974-017-0903-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-017-0903-9</ArticleId><ArticleId IdType="pmc">PMC5481928</ArticleId><ArticleId IdType="pubmed">28645309</ArticleId></ArticleIdList></Reference><Reference><Citation>Fekete R, Cser&#xe9;p C, L&#xe9;n&#xe1;rt N, T&#xf3;th K, Orsolits B, Martinecz B, et al. Microglia control the spread of neurotropic virus infection via P2Y12 signalling and recruit monocytes through P2Y12-independent mechanisms. Acta Neuropathol. 2018;136(3):461&#x2013;482. doi: 10.1007/s00401-018-1885-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1885-0</ArticleId><ArticleId IdType="pmc">PMC6096730</ArticleId><ArticleId IdType="pubmed">30027450</ArticleId></ArticleIdList></Reference><Reference><Citation>Ce&#xf1;a-Diez R, Vacas-C&#xf3;rdoba E, Garc&#xed;a-Broncano P, de la Mata FJ, G&#xf3;mez R, Maly M, et al. Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action. Int J Nanomedicine. 2016;11:2147&#x2013;2162. doi: 10.2217/nnm-2016-0095.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nnm-2016-0095</ArticleId><ArticleId IdType="pmc">PMC4876947</ArticleId><ArticleId IdType="pubmed">27274240</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinert LS, Harder L, Holm CK, Iversen MB, Horan KA, Dagn&#xe6;s-Hansen F, et al. TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J Clin Invest. 2012;122:1368&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3314467</ArticleId><ArticleId IdType="pubmed">22426207</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohashi M, Bertke AS, Patel A, Krause PR. Spread of herpes simplex virus to the spinal cord is independent of spread to dorsal root ganglia. J Virol. 2011;85(6):3030&#x2013;3032. doi: 10.1128/JVI.02426-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02426-10</ArticleId><ArticleId IdType="pmc">PMC3067948</ArticleId><ArticleId IdType="pubmed">21159869</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J, Veselenak RL, Gorder SR, Bourne N, Milligan GN. Virus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in Guinea pigs. PLoS One. 2014;9(12):1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4259353</ArticleId><ArticleId IdType="pubmed">25485971</ArticleId></ArticleIdList></Reference><Reference><Citation>Labzin LI, Heneka MT, Latz E. Innate immunity and neurodegeneration. Annu Rev Med. 2018;69(1):437&#x2013;449. doi: 10.1146/annurev-med-050715-104343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-050715-104343</ArticleId><ArticleId IdType="pubmed">29106805</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond TR, Marsh SE, Stevens B. Immune signaling in neurodegeneration. Immunity. 2019;50(4):955&#x2013;974. doi: 10.1016/j.immuni.2019.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.03.016</ArticleId><ArticleId IdType="pmc">PMC6822103</ArticleId><ArticleId IdType="pubmed">30995509</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinz M, Erny D, Hagemeyer N. Ontogeny and homeostasis of CNS myeloid cells. Nat Immunol. 2017;18(4):385&#x2013;392. doi: 10.1038/ni.3703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3703</ArticleId><ArticleId IdType="pubmed">28323268</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Neuroforum. 2005;11(3):95&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">15831717</ArticleId></ArticleIdList></Reference><Reference><Citation>Schetters STT, Gomez-Nicola D, Garcia-Vallejo JJ, Van Kooyk Y. Neuroinflammation: microglia and T cells get ready to tango. Front Immunol. 2017;8:1905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5788906</ArticleId><ArticleId IdType="pubmed">29422891</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzu P, Blauwendraat C, Heetveld S, Lynes EM, Castillo-Lizardo M, Dhingra A, et al. C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers. Acta Neuropathol Commun. 2016;4(1):37. doi: 10.1186/s40478-016-0306-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0306-7</ArticleId><ArticleId IdType="pmc">PMC4832459</ArticleId><ArticleId IdType="pubmed">27079381</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd AJ. Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci. 2010;11(12):823&#x2013;836. doi: 10.1038/nrn2947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2947</ArticleId><ArticleId IdType="pmc">PMC3277941</ArticleId><ArticleId IdType="pubmed">21068766</ArticleId></ArticleIdList></Reference><Reference><Citation>Peirs C, Seal RP. Recent advances and current views. Science (80- ) 2016;354(6312):578&#x2013;584. doi: 10.1126/science.aaf8933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf8933</ArticleId><ArticleId IdType="pubmed">27811268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiehn O. Decoding the organization of spinal circuits that control locomotion. Nat Rev Neurosci. 2016;17:224&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4844028</ArticleId><ArticleId IdType="pubmed">26935168</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Patel CD, Manivanh R, North B, Backes IM, Posner DA, et al. Maternal antiviral immunoglobulin accumulates in neural tissue of neonates to prevent HSV neurological disease. MBio. 2017;8(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5573671</ArticleId><ArticleId IdType="pubmed">28679745</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry VH, Holmes C. Microglial priming in neurodegenerative disease. Nat Rev Neurol. 2014;10(4):217&#x2013;224. doi: 10.1038/nrneurol.2014.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.38</ArticleId><ArticleId IdType="pubmed">24638131</ArticleId></ArticleIdList></Reference><Reference><Citation>Song WM, Colonna M. The identity and function of microglia in neurodegeneration. Nat Immunol. 2018;19(10):1048&#x2013;1058. doi: 10.1038/s41590-018-0212-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-018-0212-1</ArticleId><ArticleId IdType="pubmed">30250185</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickman S, Izzy S, Sen P, Morsett L, El Khoury J. Microglia in neurodegeneration. Nat Neurosci. 2018;21:1359&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6817969</ArticleId><ArticleId IdType="pubmed">30258234</ArticleId></ArticleIdList></Reference><Reference><Citation>Madore C, Yin Z, Leibowitz J, Butovsky O. Microglia, Lifestyle Stress, and Neurodegeneration. Immunity. 2020;52:222&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234821</ArticleId><ArticleId IdType="pubmed">31924476</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusinova I, Forster S, Yu S, Kannan A, Masse M, Cumming H, et al. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 2013;41:D1040&#x2013;1046.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3531205</ArticleId><ArticleId IdType="pubmed">23203888</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlpine W, Sun L, Wang KW, Liu A, Jain R, San Miguel M, et al. Excessive endosomal TLR signaling causes inflammatory disease in mice with defective SMCR8-WDR41-C9ORF72 complex function. Proc Natl Acad Sci U S A. 2018;115:E11523&#x2013;E11531.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6298088</ArticleId><ArticleId IdType="pubmed">30442666</ArticleId></ArticleIdList></Reference><Reference><Citation>Paludan SR, Bowie AG, Horan KA, Fitzgerald KA. Recognition of herpesviruses by the innate immune system. Nat Rev Immunol. 2011;11(2):143&#x2013;154. doi: 10.1038/nri2937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2937</ArticleId><ArticleId IdType="pmc">PMC3686362</ArticleId><ArticleId IdType="pubmed">21267015</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorensen LN, Reinert LS, Malmgaard L, Bartholdy C, Thomsen AR, Paludan SR. TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J Immunol. 2008;181:8604&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">19050280</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M, Hutt KR, Vu AQ, Baughn M, Huelga SC, et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci. 2012;15:1488&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>An H, Skelt L, Buchman VL, Shelkovnikova T. Antiviral immune response as a trigger of FUS proteinopathy in amyotrophic lateral sclerosis. SSRN Electron J. 2019;29(13):4496&#x2013;4508.e4. doi: 10.1016/j.celrep.2019.11.094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.11.094</ArticleId><ArticleId IdType="pmc">PMC6941233</ArticleId><ArticleId IdType="pubmed">31875556</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>